No Data
No Data
No Data
No Data
No Data
Grifols 2023 Annual Report on Form 20-F Filed With the SEC
BARCELONA, Spain, April 19, 2024 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, toda
PR Newswire04:42
Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: A $2.5 Billion Market Dominated by Alexion Pharma, Grifols, Avadel Pharma, Novartis, Pfizer, AbbVie, and Roche
Yahoo FinanceApr 17 16:05
Grifols Reportedly Looking to Appoint Independent Directors
Seeking AlphaApr 15 23:37
Market Chatter: Grifols Plans to Appoint Independent Directors Only to Audit, Compensation Committees
Grifols (GRFS) is planning to appoint independent directors only to its audit and compensation committees as part of measures to continue enhancing governance, La Vanguardia reported, citing an interv
MT NewswiresApr 15 20:38
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
cls.cnApr 15 14:37
Grifols to Add Independent Directors in Audit, Compensation Committees to Improve Governance
Grifols (GRF.MC) is looking to improve its governance by adding independent directors to its audit and compensation committees, Reuters reported Sunday, citing Spanish daily La Vanguardia. The Spanish
MT NewswiresApr 15 12:24
No Data
No Data